These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Hermida RC; Ayala DE; Mojón A; Fernández JR Am J Hypertens; 2012 Mar; 25(3):297-305. PubMed ID: 22089106 [TBL] [Abstract][Full Text] [Related]
7. A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure. Zhang DY; Guo QH; An DW; Li Y; Wang JG J Hypertens; 2019 Sep; 37(9):1775-1785. PubMed ID: 31219948 [TBL] [Abstract][Full Text] [Related]
8. Blood Pressure Out of the Office: Its Time Has Finally Come. Krakoff LR Am J Hypertens; 2016 Mar; 29(3):289-95. PubMed ID: 26547078 [TBL] [Abstract][Full Text] [Related]
9. The complexity of masked hypertension: diagnostic and management challenges. Franklin SS; Wong ND Curr Hypertens Rep; 2014 Sep; 16(9):474. PubMed ID: 25097111 [TBL] [Abstract][Full Text] [Related]
10. Masked Hypertension: How to Identify and When to Treat? Rizzoni D High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):181-6. PubMed ID: 27041372 [TBL] [Abstract][Full Text] [Related]
11. Current approach to masked hypertension: From diagnosis to clinical management. Dolan E; James K Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1272-1278. PubMed ID: 24283851 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular diastolic function evaluated by the E/e' ratio is impaired in patients with masked uncontrolled hypertension. Komori T; Eguchi K; Kabutoya T; Ishikawa J; Hoshide S; Kario K Clin Exp Hypertens; 2014; 36(8):538-44. PubMed ID: 24490643 [TBL] [Abstract][Full Text] [Related]
13. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R; Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975 [TBL] [Abstract][Full Text] [Related]
15. An Update on Masked Hypertension. Anstey DE; Pugliese D; Abdalla M; Bello NA; Givens R; Shimbo D Curr Hypertens Rep; 2017 Oct; 19(12):94. PubMed ID: 29071520 [TBL] [Abstract][Full Text] [Related]
16. Determinants of masked hypertension in the general population: the Finn-Home study. Hänninen MR; Niiranen TJ; Puukka PJ; Mattila AK; Jula AM J Hypertens; 2011 Oct; 29(10):1880-8. PubMed ID: 21841499 [TBL] [Abstract][Full Text] [Related]
17. Ambulatory blood pressure monitoring in daily clinical practice - the Spanish ABPM Registry experience. Gorostidi M; Banegas JR; de la Sierra A; Vinyoles E; Segura J; Ruilope LM Eur J Clin Invest; 2016 Jan; 46(1):92-8. PubMed ID: 26541761 [TBL] [Abstract][Full Text] [Related]
18. Masked hypertension: evaluation, prognosis, and treatment. Angeli F; Reboldi G; Verdecchia P Am J Hypertens; 2010 Sep; 23(9):941-8. PubMed ID: 20508623 [TBL] [Abstract][Full Text] [Related]
19. Home and ambulatory blood pressure monitoring in chronic kidney disease. Agarwal R Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):507-12. PubMed ID: 19713838 [TBL] [Abstract][Full Text] [Related]